Haemonetics Corp (HAE)
88.34
-0.30
(-0.34%)
USD |
NYSE |
May 24, 16:00
88.36
+0.02
(+0.02%)
After-Hours: 20:00
Haemonetics Accounts Receivable (Quarterly): 206.56M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 206.56M |
December 31, 2023 | 211.61M |
September 30, 2023 | 174.25M |
June 30, 2023 | 177.12M |
March 31, 2023 | 179.14M |
December 31, 2022 | 181.10M |
September 30, 2022 | 171.53M |
June 30, 2022 | 146.46M |
March 31, 2022 | 159.38M |
December 31, 2021 | 154.98M |
September 30, 2021 | 141.30M |
June 30, 2021 | 132.91M |
March 31, 2021 | 127.56M |
December 31, 2020 | 146.94M |
September 30, 2020 | 141.53M |
June 30, 2020 | 141.09M |
March 31, 2020 | 165.21M |
December 31, 2019 | 170.75M |
September 30, 2019 | 176.54M |
June 30, 2019 | 163.34M |
March 31, 2019 | 185.03M |
December 31, 2018 | 167.64M |
September 30, 2018 | 161.59M |
June 30, 2018 | 151.34M |
March 31, 2018 | 151.23M |
Date | Value |
---|---|
December 31, 2017 | 146.72M |
September 30, 2017 | 143.69M |
June 30, 2017 | 151.51M |
March 31, 2017 | 152.68M |
December 31, 2016 | 150.56M |
September 30, 2016 | 151.60M |
June 30, 2016 | 149.67M |
March 31, 2016 | 157.09M |
December 31, 2015 | 148.77M |
September 30, 2015 | 145.41M |
June 30, 2015 | 139.10M |
March 31, 2015 | 145.83M |
December 31, 2014 | 143.64M |
September 30, 2014 | 151.06M |
June 30, 2014 | 156.73M |
March 31, 2014 | 164.60M |
December 31, 2013 | 149.58M |
September 30, 2013 | 162.08M |
June 30, 2013 | 155.96M |
March 31, 2013 | 170.11M |
December 31, 2012 | 167.35M |
September 30, 2012 | 158.18M |
June 30, 2012 | 126.13M |
March 31, 2012 | 135.46M |
December 31, 2011 | 127.44M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
127.56M
Minimum
Mar 2021
211.61M
Maximum
Dec 2023
163.46M
Average
164.27M
Median
Accounts Receivable (Quarterly) Benchmarks
ResMed Inc | 779.26M |
Stryker Corp | 3.473B |
InfuSystems Holdings Inc | 20.54M |
Perspective Therapeutics Inc | 0.999M |
Xtant Medical Holdings Inc | 21.48M |